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Glioblastomas (GBM) may receive inadequate radiation dose 
coverage, specially the nonenhanced hypercellular 
component, using post-Gd T1 weighted and T2 FLAIR images 
for radiation target definition. A mixture of edema, micro-
necrosis, tumor cells and normal tissue in a single image 
voxel result in an unpredictable value on diffusion images 
using a conventional b-value of 1000 s/mm2 or less. This 
study aimed to develop a technique to identify the 
hypercellular components of GBM by using high b-value 
diffusion weighted imaging (DWI) to suppress fluid, edema, 
micro-necrosis and even normal tissue to an extent.  The 
hypercellular volume (HCV) of the tumor was evaluated for 
radiation dose coverage and prediction of progression-free 
survival (PFS). 
Forty patients with newly diagnosed GBM underwent 
chemoradiotherapy post-resection/biopsy. The target 
definition was based upon conventional MRI and RT 
treatment planning followed standard guidelines.  Pre-RT 
DWI was acquired with b-values of 0, 1000, and 3000 s/mm2. 
A HCV was defined on the DWI with b=3000 s/mm2 by a 
threshold obtained from normal tissue.  The nonenhanced 
HCV was delineated by comparing to the Gd-enhanced gross 
tumor volume (GTV-Gd) on T1-weighted images. Radiation 
coverage of the HCV was evaluated by the 95% prescribed 
dose-volume (95%PDV) of the planned dose distribution.  
Association between HCV and PFS or other clinical covariates 
were assessed using univariate proportional hazards 
regression models. 
For the first 21 patients with a minimum follow-up of 18 
months, the HCVs varied 0.58-67 cc (median: 9.8cc), 7 times 
smaller than the FLAIR-defined CTV.  The non-enhanced HCV 
was 0.15-60 cc (median: 2.5cc). However, incomplete dose 
coverage of the HCV was seen in 14 patients, in whom 6 had 
at least 1-cc HCV missed by the 95%PDV (range: 1.01-25.4cc). 
Of the 21 patients, 15 had progressed, 5 patients earlier 
within 6 months post-RT, and 10 patients >6 months post-RT.  
HCV and nonenhanced HCV were significant negative 
predictors for PFS (p<0.002 and p<0.01, respectively). The 
component of the HCV that was not covered by the 95%PDV 
was a significant negative predictor for PFS (p<0.05).  The 
proportion of pre-RT HCVs that overlapped with recurrent 
Gd-enhanced tumor volume was 78% (range: 65-89%) for the 5 
earlier progressors, and 53% (range: 0-85%) for the later 
progressors.   
The HCV identified by high b-value DWI most likely 
represents an aggressive component of the tumor, and 
analysis of the data from the whole cohort is in progress.  
Pathological validation is on-going.  Post-Gd T1 weighted 
images (a qualitative measure of vascular leakage) and T2 
FLAIR images (influenced by edema) are not adequate for 
radiation target definition of GBM. Selectively boosting the 
HCV component of GBM will be tested in a prospective 
clinical trial. 
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Fig 1. Diffusion weighted images with b=3000. Yellow: HCV; 
Red: post-Gd GTV; Pink: 95%PDV. 
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Early assessment of therapeutic response in NSCLC is of 
major importance to individualize treatment, ultimately 
improving outcome. Radiomics comprises the extraction of a 
large set of quantitative descriptors from medical images (1). 
We hypothesised that a Radiomics analysis of variation of 
metabolic uptake patterns of repeated FDG-PET (Figure 1) 
allows early response assessment and validated our findings 
in external datasets. 
A prospective dataset of 54 stage IIIa-IV NSCLC patients 
referred for radical (chemo)radiotherapy was used for 
prediction model development. The validation datasets 
included 32 stage IIb-IIIb (details in (2)) and 26 stage IIa-IIIb 
(details in (3)) NSCLC patients. FDG-PET scans were acquired 
before and during second week of radiotherapy. Radiomics 
analysis included descriptors of shape and size, first order 
statistics, textural information [run-length grey level (RLGL), 
grey level co-occurrence (GLCM) and grey level size zone 
matrices (GLSZM)] and intensity volume histograms (IVH). For 
analysis, solely features with a high intraclass correlation 
(ICC) on both test-retest and inter-observer stability analysis 
were kept (4). Cox Proportional Hazard Regression was 
performed for overall survival assessment, with the relative 
percentage variation of each feature between subsequent 
scans as continuous covariates: 
 
ICTR-PHE 2016  S21 
 
A least absolute shrinkage and selection operator (LASSO) 
method was used for feature selection. Model performance 
was evaluated using Harrell’s concordance-index (c-index). 
Fitted model included sum entropy (GLCM), high intensity 
large area emphasis (GLSZM), volume with a minimum 
relative intensity of 60% of the maximum SUV – AVRI60% 
(IVH), grey level non-uniformity and long run emphasis 
(RLGL) and volume (shape) – Table 1. Internal performance of 
the model was 0.64 (p<0.01), while externally it achieved a 
performance of 0.61 (p = 0.05) and 0.58 (0.20), with no 
further calibration done. Maximum and mean SUV had a 
univariable performance in the training data of 0.51 and 
0.55, respectively. 
The reduced accuracy of the model validation can be 
associated with dissimilarities among data, particularly the 
different timing and delivered dose of the second scan. 
Nevertheless, we do see benefit on a timely assessment of 
response to radiotherapy using the described imaging 
analysis, particularly when compared with the limited 
capacity of humans to infer accurate predictions and risk 
groups identification (5). From the Radiomics analysis one 
can optimally benefit from early response metrics based on 
changes in metabolism measured with FDG-PET, even before 
anatomic changes become noticeable, while treatment can 
still be adapted.  
We developed and validated a predictive model on the 
percentage variation of Radiomics features, the so-called 
“Delta Radiomics” concept, from repeated FDG-PET scans of 
NSCLC patients. 
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Purpose: Proton radiography is an imaging technique in 
proton therapy giving direct information on the density of the 
tissues, a useful tool to enhance the precision of proton 
therapy. It is usually performed as a proton range 
radiography by measuring the position and the residual range 
of the protons after the target. The properties of the 
traversed materials are directly related to multiple 
scattering so that it is possible to obtain an image through 
the assessment of the proton angular distribution. This work 
aims at studying the possibility of performing proton 
scattering radiography using only one nuclear emulsion film. 
Materials and methods: Nuclear emulsion films allow for high-
precision tracking of charged particles and, in particular, for 
reconstructing their angular distribution with a resolution of 
the order of 1 mrad. Specific detectors for medical 
applications can be built by interposing double-sided 
emulsion films with tissue equivalent materials, as it was 
done for proton range radiography [1] and to study the halo 
of a proton pencil beam [2]. In the present study, a detector 
composed by only one emulsion film was exposed to a 138 
MeV proton pencil beam at the Gantry 1 at PSI. Two 
phantoms were placed in front of the detector: the “step” 
phantom consisted of two different thicknesses of PMMA (3 
and 4 cm, respectively); the “rod” phantom had a total 
thickness of 4.5 cm and contained five aluminum rods (5 × 5 
mm2 section) positioned at different depths in a PMMA 
structure. Following the chemical development and the 
automatic microscopic scanning of the emulsion film, proton 
tracks were identified and their angular distribution 
reconstructed. 
Results: The RMS of the scattering angle was measured for 
different segmentations of the emulsion film. Areas were 
chosen as strips parallel to the direction of the step or of the 
rods, for the first and the second phantom, respectively. To 
evaluate the resolution, strips of different sizes were 
considered. As shown in figure 1 (left), the step is clearly 
identified as a sharp drop of the RMS of the scattering angle. 
The signal due to the rods is visible as an enhancement of the 
RMS corresponding to their positions. The rod located nearest 
to the detector shows a sharper peak while the farthest one 
appears broader due to the larger distance travelled by the 
protons. While the contrast for the step phantom is found to 
be basically the same for range and scattering proton 
radiography, the signal due to the rods is more evident with 
respect to what was obtained with proton range radiography 
[1]. These preliminary results suggest that atomic number 
plays a fundamental role to increase the contrast of the 
image.  
Conclusions: A feasibility study of proton scattering 
radiography with a new method based on a single emulsion 
detector has been performed. The first preliminary results 
are promising and further studies are under way 
encompassing in particular Monte Carlo simulations. 
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